E
Elham Sajjadi
Researcher at European Institute of Oncology
Publications - 57
Citations - 538
Elham Sajjadi is an academic researcher from European Institute of Oncology. The author has contributed to research in topics: Breast cancer & Medicine. The author has an hindex of 9, co-authored 28 publications receiving 163 citations. Previous affiliations of Elham Sajjadi include Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico & Shahid Beheshti University of Medical Sciences and Health Services.
Papers
More filters
Journal ArticleDOI
The evolving landscape of Anatomic Pathology.
Pasquale Pisapia,Vincenzo L'Imperio,Francesca Galuppini,Elham Sajjadi,Alessandra Russo,Bruna Cerbelli,Filippo Fraggetta,G. d’Amati,Giancarlo Troncone,Matteo Fassan,Nicola Fusco,Fabio Pagni,Umberto Malapelle +12 more
TL;DR: Anatomic pathology has changed dramatically in recent years as mentioned in this paper and pathologists have had to acquire additional knowledge to bridge the gap between clinicians and molecular biologists, which is particularly important as cases are now collegially discussed in molecular tumor boards (MTBs).
Journal ArticleDOI
Low-risk triple-negative breast cancers: clinico-pathological and molecular features.
Nicola Fusco,Elham Sajjadi,Konstantinos Venetis,Mariia Ivanova,S. Andaloro,Elena Guerini-Rocco,Emilia Montagna,Pietro Caldarella,Paolo Veronesi,Marco Colleoni,Giuseppe Viale +10 more
TL;DR: In this paper , the authors provided a portrait of the clinicopathological and molecular features of low-risk triple negative breast cancer, with a focus on the diagnostic challenges along with the most important biological characteristics underpinning their favorable clinical course.
Journal ArticleDOI
Increased expression ratio of matrix metalloproteinase-9 (MMP9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) RNA levels in Iranian multiple sclerosis patients.
Marzieh Khoshbin Nazdik,Mohammad Taheri,Mohammad Taheri,Elham Sajjadi,Shahram Arsang-Jang,Zeinab Kazaei Koohpar,Hidetoshi Inoko,Arezou Sayad +7 more
TL;DR: Although there was no significant decrease in TIMP-1 expression level, the MMP-9/TIMp-1 RNA ratio in RRMS was significantly higher than normal subjects, and further studies are recommended to compare M MP-9-to-TIMP-2RNA ratio in patients before and after taking IFN-beta in order to find out if it can function as a proper marker of the bio efficacy of IFn-beta treatment of MS.
Journal ArticleDOI
Lymphedema Rehabilitation Using Self-Adaptive Inelastic Compression in Breast Cancer: A Proof-of-Principle Study
TL;DR: It is suggested that IC could be considered as a safe, well-tolerated, and effective tool in the rehabilitative management of BCRL patients.
Journal ArticleDOI
Mismatch Repair Status Characterization in Oncologic Pathology: Taking Stock of the Real-World Possibilities
TL;DR: The indications and challenges in MMR status assessment for molecular pathologists are highlighted, focusing on the possible strategies to overcome analytical and pre-analytical issues.